Biomarkers of environmental tobacco smoke exposure.

Biomarkers are desirable for quantitating human exposure to environmental tobacco smoke (ETS) and for predicting potential health risks for exposed individuals. A number of biomarkers of ETS have been proposed. At present cotinine, measured in blood, saliva, or urine, appears to be the most specific and the most sensitive biomarker. In nonsmokers with significant exposure to ETS, cotinine levels in the body are derived primarily from tobacco smoke, can be measured with extremely high sensitivity, and reflect exposure to a variety of types of cigarettes independent of machine-determined yield. Under conditions of sustained exposure to ETS (i.e., over hours or days), cotinine levels reflect exposure to other components of ETS. Supporting the validity of cotinine as a biomarker, cotinine levels have been positively correlated to the risks of some ETS-related health complications in children who are not cigarette smokers. ImagesFigure 1

[1]  N. Benowitz,et al.  Cotinine as a biomarker of environmental tobacco smoke exposure. , 1996, Epidemiologic reviews.

[2]  J. Ockene,et al.  Occupational exposure to environmental tobacco smoke. , 1996, JAMA.

[3]  T B Cooper,et al.  Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  G. Pershagen,et al.  PARENTAL SMOKING, URINARY COTININE, AND WHEEZING BRONCHITIS IN CHILDREN , 1995, Epidemiology.

[5]  J. Lewtas,et al.  DNA adducts and personal air monitoring of carcinogenic polycyclic aromatic hydrocarbons in an environmentally exposed population. , 1995, Carcinogenesis.

[6]  M. Woodward,et al.  Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study. , 1995, Journal of epidemiology and community health.

[7]  E. Perez-stable,et al.  Is serum cotinine a better measure of cigarette smoking than self-report? , 1995, Preventive medicine.

[8]  P. Nafstad,et al.  Comparison of three methods for estimating environmental tobacco smoke exposure among children aged between 12 and 36 months. , 1995, International journal of epidemiology.

[9]  N. Benowitz,et al.  Metabolism of nicotine to cotinine studied by a dual stable isotope method , 1994, Clinical pharmacology and therapeutics.

[10]  F. Perera,et al.  Biomarkers of environmental tobacco smoke in preschool children and their mothers. , 1994, Journal of the National Cancer Institute.

[11]  N. Benowitz,et al.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation. , 1994, The New England journal of medicine.

[12]  G Levy,et al.  Concentration‐ or effect‐controlled clinical trials with sparse data , 1994, Clinical pharmacology and therapeutics.

[13]  James L. Repace.  Dietary nicotine: Won't mislead on passive smoking…: New insight into myocardial protection , 1994, BMJ.

[14]  G. Hageman,et al.  DNA adduct and mutation analysis in white blood cells of smokers and nonsmokers , 1994, Environmental and molecular mutagenesis.

[15]  S. Hecht,et al.  A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. , 1993, The New England journal of medicine.

[16]  E. Domino,et al.  The nicotine content of common vegetables. , 1993, The New England journal of medicine.

[17]  James L. Repace,et al.  An enforceable indoor air quality standard for environmental tobacco smoke in the workplace. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[18]  N. Haley,et al.  Measuring exposure to environmental tobacco smoke in studies of acute health effects. , 1993, American journal of epidemiology.

[19]  S. Tannenbaum,et al.  Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. , 1993, Journal of the National Cancer Institute.

[20]  Oar,et al.  Respiratory health effects of passive smoking: lung cancer and other disorders , 1993 .

[21]  N. Benowitz,et al.  Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers , 1993, Clinical pharmacology and therapeutics.

[22]  D. Strachan,et al.  Relation of passive smoking as assessed by salivary cotinine concentration and questionnaire to spirometric indices in children. , 1993, Thorax.

[23]  S. Lehrer,et al.  Assessment of multiple markers of environmental tobacco smoke (ETS) in controlled, steady-state atmospheres in a dynamic test chamber. , 1992, American Industrial Hygiene Association journal.

[24]  M. W. Ogden,et al.  Effect of ventilation and sampling time on environmental tobacco smoke component ratios , 1992 .

[25]  M. Jarvis,et al.  Exposure to passive smoking among bar staff. , 1992, British journal of addiction.

[26]  K. Hemminki,et al.  DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlabelling assay. , 1991, Carcinogenesis.

[27]  S. Kira,et al.  Respiratory nicotine absorption in non-smoking females during passive smoking , 1991, International archives of occupational and environmental health.

[28]  J. Reynolds,et al.  Dietary nicotine: a source of urinary cotinine. , 1991, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[29]  P. Vineis,et al.  Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. , 1990, Journal of the National Cancer Institute.

[30]  J. Samet,et al.  A personal monitoring study to assess workplace exposure to environmental tobacco smoke. , 1990, American journal of public health.

[31]  D. Strachan,et al.  The relationship of salivary cotinine to respiratory symptoms, spirometry, and exercise-induced bronchospasm in seven-year-old children. , 1990, The American review of respiratory disease.

[32]  N. Wald,et al.  Relation of urinary cotinine concentrations to cigarette smoking and to exposure to other people's smoke. , 1990, Thorax.

[33]  R. Etzel.  A review of the use of saliva cotinine as a marker of tobacco smoke exposure. , 1990, Preventive medicine.

[34]  G. Lucier,et al.  Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabeling analysis. , 1990, Carcinogenesis.

[35]  J. Idle,et al.  Titrating exposure to tobacco smoke using cotinine--a minefield of misunderstandings. , 1990, Journal of clinical epidemiology.

[36]  E. Miesner,et al.  Particulate and nicotine sampling in public facilities and offices. , 1989, JAPCA.

[37]  N. Benowitz,et al.  Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. , 1989, Circulation.

[38]  R. Katz,et al.  Elevated blood levels of carcinogens in passive smokers. , 1989, American journal of public health.

[39]  M. Karol,et al.  Effects of passive smoking on theophylline clearance , 1989, Clinical pharmacology and therapeutics.

[40]  M. W. Ogden,et al.  Collection and determination of solanesol as a tracer of environmental tobacco smoke in indoor air , 1989 .

[41]  J. Lewtas,et al.  Home air nicotine levels and urinary cotinine excretion in preschool children. , 1989, The American review of respiratory disease.

[42]  D. Strachan,et al.  Passive smoking, salivary cotinine concentrations, and middle ear effusion in 7 year old children. , 1989, BMJ.

[43]  C. L. Benner.  Chemical composition of environmental tabacco smoke. Particulate - phase compounds , 1989 .

[44]  J. D. Lamb,et al.  Chemical composition of environmental tobacco smoke. 1. Gas-phase acids and bases , 1989 .

[45]  J. W. Crawford,et al.  The chemical composition of environmental tobacco smoke III. Identification of conservative tracers of environmental tobacco smoke , 1989 .

[46]  S. Sheen.  Detection of Nicotine in Foods and Plant Materials , 1988 .

[47]  N. Benowitz,et al.  Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. , 1988, American journal of public health.

[48]  L. Bates.  ENVIRONMENTAL TOBACCO SMOKE: MEASURING EXPOSURES AND ASSESSING HEALTH EFFECTS , 1987 .

[49]  H. Tunstall-Pedoe,et al.  Biochemical markers of smoke absorption and self reported exposure to passive smoking. , 1984, Journal of epidemiology and community health.

[50]  G. Scherer,et al.  Hydroxyproline excretion in urine of smokers and passive smokers. , 1984, Preventive medicine.

[51]  N. Haley,et al.  Tobacco sidestream smoke: uptake by nonsmokers. , 1984, Preventive medicine.

[52]  J. Robinson,et al.  Yields of tar, nicotine, and carbon monoxide in the sidestream smoke from 15 brands of Canadian cigarettes. , 1984, American journal of public health.

[53]  M. Jarvis,et al.  Absorption of nicotine and carbon monoxide from passive smoking under natural conditions of exposure. , 1983, Thorax.

[54]  R. Herning,et al.  Smokers of low-yield cigarettes do not consume less nicotine. , 1983, The New England journal of medicine.

[55]  R. Bos,et al.  Excretion of mutagens in human urine after passive smoking. , 1983, Cancer letters.

[56]  D. Petitti,et al.  Prevalence and correlates of passive smoking. , 1983, American journal of public health.

[57]  Benowitz Nl.  The use of biologic fluid samples in assessing tobacco smoke consumption. , 1983 .

[58]  J. Harington.  Environmental Health Perspectives , 1976 .